Severe eosinophilia associated with cholangiocarcinoma I t is widely recognised that eosinophils are found in tumor infltrates and that their mechanism of action is associated with particular symptoms and prognosis. However, the causes of and reasons for this process remain unclear, as does the exact mechanism by which it occurs. We report on the case of a 71-year-old woman with cholangiocellar carcinoma (CCC) with a marked eosinophilia. When the patient presented at the hospital, she said she was sufering from fatigue, depression, and pain. Tat triad of symptoms, indicative of peripheral eosinophilia (TABE, or tumor-associated blood eosinophilia) and tissue eosinophilia (TATE, or tumor-associated tissue eosinophilia), are recurrent in oncology. We also conducted a structured review of literature on eosinophilia associated with biliary tumors to try to answer 3 questions: Is eosinophilia (TABE or TATE) associated with solid tumors, with particular reference to the tumor of the bile duct? Is eosinophilia in biliary tumors associated with specifc symptoms? Does eosinophilia (TABE or TATE) predict a specifc prognosis?
Case presentation and summary
In May 2014, a 71-year-old woman was admitted to the hospital with a range of symptoms including fatigue, depression, and vague abdominal pain during the preceding 4 months.When frst examined by the hematologist, she was presenting with subicterus. Te patient's hepatic tests were altered (alanine transaminase [ALT], 58 U/L; alkaline phosphatase [ALP], 1308 U/L; gamma-glutamyl transferase [GGT] , 2189 U/L), and marked leukocytosis with eosinophilia and neutrophilia were shown: white blood cell (WBC) count, 48490/ mmc; neutrophils (N), 20850/mmc; monocytes (M), 4850/mmc; eosinophils (E), 18910/mmc; lymphocytes (L), 3880/mmc. As a result, she underwent abdominal ultrasound inspection in the the emer-gency department. Te ultrasound showed multiple nodules hypoechoic on liver, a lesion of 6.75 cm (2.7 in) the pancreatic region (between the pancreatic body and head), swollen intrahepatic bile duct, especially the left duct, and multiple peripancreatic and perihepatic lymphadenopathy. Te chest X-ray was negative for parenchymal lesions.
Te patient said she had no family history of allergies, had not traveled to a foreign country, did not use or abuse drugs, and had not had any direct exposure to chemicals. She had essential hypertension and a smoking habit. In 1986, she developed 2 brain aneurysm ruptures for which she underwent brain surgery, which was complicated by cerebral ischemia with hemiparesis on both sides and aphasia. Afterward, notable improvements were recorded but always with aphasia. In 2010, she experienced progressive locomotor performance decline. Te patient was taking therapy: ACE inhibitor, statin, cardioaspirin, prophylactic phenobarbitral, selegiline, and proton pump inhibitors.
Te physical examination revealed subicterus and moderate abdominal tenderness in the patient, who was observant, but aphasic. Clinical laboratory outcomes confrmed severe leukocytosis with hypereosinophilia (WBC, 48820 cells/mmc; N, 20800/mmc; E, 0640/mmc; L, 2390/mmc; M, 4520/mmc; B 70/ mmc); increased necrosis and stasis liver tests (ALT, 50 U/L; ALP, 1156 U/L; GGT, 1993 U/L); total bilirubin, 2.83 mg/dL; direct bilirubin (D-bil), 2.53 mg/dL; macrocytosis (MCV), 103 fL; a decrease in folate (7.9 nmol/L); an increase in prothromin time (PT, 1.6 sec); biological infammatory syndrome (CRP, 73.3 mg/L); mild polyclonal increase in gamma globulins (19.5%); hyperferritemia (778 Ug/L); and increased IgE (306 U/ml). Tryptase examination was not performed. Other exams were either normal or negative: total complement activity tests (C3, C4), ANCA, ANA refex, HIV, immuno-globulis, Bence Jones in the urines, systemic IgG, and subclasses. Stool culture for fecal parasites was negative.
We frst took into account a diferential diagnosis of secondary eosinophilia, which are extensive and include allergic diseases, drug-induced eosinophilias, hematologic disorders, neoplastic disorders, and parasitic infections (mainly helminthes). Ten we developed the following diagnostic hypotheses: CCC with liver metastases and secondary eosinophilia, pancreatic cancer with secondary eosinophilia, primary sclerosing cholangitis (PSC) associated with eosinophilia, hypereosinophilic syndrome afecting the bile duct, secondary sclerosing cholangitis (IgG4related autoimmune pancreatitis associated with sclerosing cholangitis, intraductual lithiasis hepatic infammatory pseudotumor, AIDS-related cholangiopathy), parasites (fuke, opsithorchiasis, and clonorchiasis).
A contrast-enhanced computed-tomography (CT) scan of the abdomen and thorax showed multiple confuent hepatic lesions (relative sparing of VI, VII, VIII segments); a lesion (58 x 39 mm [2.28 x 1.53 in.]) in the hilar and cefalopancreatic region, which was not separable, displaced the vascular structures, and compressed the vein and the common hepatic artery; and mild dilatation of the intrahepatic bile duct ( Figure  1 ). Te fndings were interpreted as compatible with CCC or primitive neoplasm of pancreatic head with liver metastases.
A CT scan of the brain showed chronic vascular encephalopathy and the results of an electrocardiogram (ECG) test were normal. In the end, the radiological appearance suggested a CCC. However, there were other possibilities. First, the high eosinophilia count left open the possibility of a diagnosis for parasitosis, as detected through serologic tests. Our patient had not travelled outside of Italy, therefore she did not undergo any of those tests able to detect the parasites inhabiting in the tissue and blood. Second, administration of predni-sone (40 mg/day) was instated for treating a presumed hypereosinophilic syndrome (HES). Indeed, HES (defned by an eosinophil count >1500 cells/mm 3 , the absence of apparent causes for eosinophilia, and organ system damage) and chronic eosinophilic leukemia (CEL), a term used when there is a clonal population, are malignancies characterised by sustained idiopathic hypereosinophilia, which most commonly tend to afect the heart, skin, and nervous system through eosinophilis infltration. Typically HES is not likely to involve liver and bilary tracts, however, cholecystitis chronic, hepatitis, and sclerosing eosinophilic cholangitis had been found and described, so we could not rule out a HES.
Primary sclerosing cholangitis does not respond to prednisone (except variant IgG4, but Ig subtypes were normal) as happened in our case.
We performed a biopsy of the left liver. Te histologic test revealed malignant epithelial proliferation with areas of necrosis and extensive areas of stroma collagen: atypical cells forming glandular structures, simple and complex papillae and focal solid areas with widespread mitosis. Extensive stroma and tumor eosinophilic infltrates were identifed in the lesion area. Parenchyma and periportal spaces were also present. Immunohistochemitry showed strong and widespread positivity in proliferating cells for cytokeratin 7 and 19 and moderate for CDX2, focal positivity for cytokeratin 20 and thyroid transcription factor-1 (TTF1). Te proliferation index was 65%.
Tese fndings were interpreted to be compatible with moderately or poorly diferentiated CCC with eosinophils found in large parts of tissue ( Figure 2 ).
Because of the patient's declining condition, we did not perform echocardiogram tests. Te bone marow biopsy, which is a mandatory examination to rule out the hematological malignancy, which was highly suspected because of the high Case Report levels of total WBC (about 50000/mmc), could have been not performed because of the patient's rapid decline. However, the rapid progression to death may be considered secondary to the course of a hematological disease rather than that of a CCA, whereby on the contrary, the levels of function liver tests (FLTs) did not foresee such a dramatic evolution. Moreover, serum ALP levels, which were markedly elevated in this case, can be increased in several haematological malignancies
Discussion
We conducted an extensive and systematic research in PubMed using the mesh term eosinophilia, bile duct tumors, eosinophilia, and cholangiocarcinoma. Te flters were adults, English, human beings, and the date range was January 1, 1985 to July 23, 2014. Tat search yielded 3 case reports and cases series and an observational prospective study. [1] [2] [3] [4] Two cases were excluded because they were not presented in English, 5, 6 as were cases that presented eosinophilia related to parasitic infections (Table) . [7] [8] [9] Cluster symptoms, such as fatigue, depression, and pain, and eosinophilia in bile duct tumors are strongly linked. 1 On average, 3 or more symptoms have been found and linked to each other. [10] [11] [12] [13] [14] Among the selected studies that we examined, the observational study of large series 1 is characterized by this triad of recurrent symptoms in onco-logical disorders. By contrast, in the other cases 2,3 and the observational study of large series, 4 only pain is present.
In this regard, the National Cancer Institute has stated that fatigue, depression, and pain are the most common symptoms and the most undertreated symptoms in patients with cancer. 15 Te symptoms are present in 25% of patients with hepatobiliary cancer, and by 6 months after the diagnosis of cancer, the cluster is recorded in 62%-85% of cases reference. 1 Finally, in the larger observational studies, high levels of pain, fatigue and depression, high levels of eosinophilis were observed during the frst 3-6 months of follow-up in patients with cancer. 1 Study fndings have suggested that the 3 symptoms can indicate an underlying biological mechanism. 1, 11, 14, 16, 17 Numerous elements seem to be involved in the immunological model (cytokine IL-3, IL-5, GM CSF secretion of IL-1, IFN-gamma, IL-2, IL-6, monoamine metabolism, ACTH resistance to glucocorticoid receptors, L-trypotophan reduction). Indeed, eosinophils are frequently observed in immunotherapy with IL-2, IL-4, IL-9, granulo-cytemacrophage colony-stimulating factor, and antibody to CTLA-4 16.
Our case was characterized by the presence of TABE and TATE, but poor prognosis, as with the 2 cases we cite, 2,3 which also showed a poor prognosis, although there was no prognosis in the case series. 4 By contrast, in the large observa-
Histology
Moderately differentiated adenocarcinoma of bile duct and dense periductal fbrosis on biopsy specimen. On autopsy, mucin-producing, poorly differentiated adenocarcinoma of the bile duct.
Prognosis/follow-up
The patient died from pulmonary embolism after 2 y.
Conclusions, confounding bias TABE is not associated with a good prognosis. Confounding bias Hypereosinophilic syndromes could not also be ruled out. tional study, 1 TABE showed a noticeable positive prognosis for patients with hepatobiliary carcinoma, although TATE and TABE can be observed independently and TABE was frequently observed in metastatic and advanced diseases. Te literature fails to provide an adequate answer to these questions and remains vague and inconsistent. Te mechanism of the recruitment of eosinophils into the tissue of tumors also remains unclear. 16 On the one hand, it has been suggested that eosinophils regulate tumor necrosis (through cytokine pattern, immune response, vascular permeability and muscle contraction, toxic granules releases). 17 Typically, eosinophils are strongly linked to necrotic areas and the cytotoxic afect caused by eosinophils on tumor cells in vitro and in vivo is undeniable. On the other hand, the increased activation of eosinophils in allergic patients and in some eosinophilia-associated diseases can perform both a destructive/ exacerbating and reparatory role. 16 In addition, tumor-associated eosinophils perform at least 2 unrelated functions. 16, 17 Te frst is a destructive function, whereby they are potentially limiting the tumor growth and stimulate the recruitment/activation of other leukocytes. Indeed, the concept of TABE-and TATE-promoted innovations in the treatment of cancers and the execution of TABE after the therapy seems to be associated with a better prognosis in solid tumors. Te frst of such therapies include kinase inhibitors, imatinib, sorafenib. Te second function is immunoregulative or remodelling, whereby they suppress the immune response and cause the tumor proliferation.
Some studies 16, 17 have clearly shown an improved prognosis with TATE regardless of the degree of vascular invasion (or evidence of eosinophils degranulation) in various types of solid tumors. Tese include colon tumors, oral squamous cell carcinoma, esophageal squamous cell carcinoma, nasopharyngeal carcinoma, penile cancer, laryngeal carcinoma, pulmonary adenocarcinoma, bladder carcinoma prostate cancer. Tis benefcial infuence of eosinophil in tumors activity seem to be independent from other common (standard) factors such as degree of progression, age, sex, alcohol and tobacco consumption, histologic grading, vascularisation, vascular invasion and neural invasion. Tese fndings need further research to investigate whether there is or not a correlation or a mere association.
On the other hand, TATE is highly associated with poor prognosis in other tumors such as Hodgkin lymphoma, which is frequently characterised by a tumor mass consisting of an infammatory infltrate suggesting immune deregulation by this B-cell tumor. Often, TABE and TATE occur in carcinomas mucino secernentes (intestine, pancreas, bronchi, uterus) where they indicate and widespread tumor and metastases. In the end, the reports on solid tumors, such as oral SCC or cervical carcinoma, suggest that TATE is an indicator of poor prognosis. 17 Te role of hypereosinophilia in malignant disease remains obscure, but frst of all, certainly among the various causes of hypereosinophilia, clinicians should consider the presence of a solid and hematological tumor. Answering the 3 questions posed at the outset of this report (p. 173) could be a good starting point for developing prognostic criteria.
